Article
Distinct Functional Alterations and Therapeutic Options of Two Pathological De Novo Variants of the T292 Residue of GABRA1 Identified in Children with Epileptic Encephalopathy and Neurodevelopmental Disorders.
International journal of molecular sciences - 1 Mar 2022
Chen Wenlin, Ge Yang, Lu Jie, Melo Joshua, So Yee Wah, Juneja Romi, Liu Lidong, Wang Yu Tian
Abstract excerpt
Mutations of GABAAR have reportedly led to epileptic encephalopathy and neurodevelopmental disorders. We have identified a novel de novo T292S missense variant of GABRA1 from a pediatric patient with grievous global developmental delay but without obvious epileptic activity. This mutation coincidentally occurs at the same residue as that of a previously reported GABRA1 variant T292I identified from a pediatric...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
